Crystal structure of ovine interferon-τ at 2.1 Å resolution

Journal of Molecular Biology

Volumn 286, Issue 1, 1999, Pages 151-162

  Radhakrishnan, Ramaswamy ^c   Walter, Leigh J ^c   Subramaniam, Prem S ^b   Johnson, Howard M ^b   Walter, Mark R ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c NONE

Author keywords

Cytokine; Four helix bundle; Pregnancy hormone; Type I interferon; X ray structure

Indexed keywords

TAU INTERFERON; TRYPTOPHAN;

AMINO ACID SEQUENCE; ARTICLE; CRYSTAL STRUCTURE; DRUG ACTIVITY; EMBRYO DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; SHEEP; SITE DIRECTED MUTAGENESIS;

EID: 0033548060     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1998.2480     Document Type: Article

References (64)

1. Abdel-Meguid S. S., Shieh H.-S., Smith W. W., Dayringer H. E., Violand B. N., Bentle L. A. Three-dimensional structure of a genetically engineered variant of porcine growth hormone. Proc. Natl Acad. Sci. USA. 84:1987;6434-6437.
2. Barbieri G., Velazquez L., Scrobogna M., Fellous M., Pellegrin S. Activation of the protein tyrosine kinase tyk2 by interferon α/β Eur. J. Biochem. 232:1994;427-435.
3. Baron S., Tyring S. K., Fleischmann W. R., Coppenhaver D. H., Neisel D. W., Klimpel G. R., Stanton G. J., Hughes T. K. Mechanisms of action and clinical applications. J. Am. Med. Assoc. 266:1991;1375-1383.
4. Brunger A. T. X-PLOR, Manual Version 3.1. 1991;Yale University Press, New Haven.
5. Brunger A. T. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature. 355:1992;472-475.
6. Brunger A. T., Adams P. D., Clore G. M., DeLano W. L., Gros P., Grosse-Kunstleve W., Jian J., Kuszewski J., Nilges M., Pannu N. S., Read R. J., Rice L. M., Simonson T., Warren G. L. Crystallography and NMR system (CNS): a new software suite for macromolecular structure determination. Acta. Crystallog. sect. D. 54:1998;905-921.
7. Cambillau C., Horjales E. TOM: a FRODO subpackage for protein-ligand fitting with interactive energy minimization. J. Mol. Graph. 5:1987;175-177.
8. Carson M. Ribbons 2. 0. J. Appl. Crystallog. 24:1991;958-961.
9. CCP4. The CCP4 Suite: programs for protein crystallography. Acta Crystallog. sect. D. 50:1994;760-763.
10. Chang N. T., Kung H-F., Pestka S. Synthesis of a human leukocyte interferon with a modified carboxy terminus in Escherichia coli. Arch. Biochem. Biophys. 221:1983;585-589.
11. Cheetham B. F., McInnes B., Mantamadiotis T., Murray P. J., Ålin Per Bourke P., Linnane A. W., Tymms M. J. Structure-function studies of human interferon-α: enhanced activity on human and murine cells. Antiviral Res. 15:1991;27-40.
12. Cohen B., Novick D., Barak S., Rubinstein M. Ligand-induced association of the type I interferon receptor components. Mol. Cell. Biol. 15:1995;4208-4214.
13. Colamonici O. R., Platanias L. C., Domanski P., Handa R., Gilmour K. C., Diaz M. O., Reich N., Pitha-Rowe P. Transmembrane signaling by the α subunit of the type I interferon receptor is essential for activation of the jak kinases and the transcriptional factor ISGF3. J. Biol. Chem. 270:1996;8188-8193.
14. Cook J. R., Cleary C. M., Mariano T. M., Izotova L., Pestka S. Differential responsiveness of a splice variant of the human type I interferon receptor to interferons. J. Biol. Chem. 271:1996;13448-13453.
15. Cowtan K. 'DM' an automated procedure for phase improvement by density modification. Bailey S., Wilson K. Joint CCP4 and ESF: EACBM Newsletter on Protein Crystallography. 1994;34-38 Dansbury Laboratory, Hamburg.
16. de Vos A. M., Ultsch M., Kossiakoff A. A. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science. 255:1991;306-312.
17. Domanski P., Witte M., Kellum M., Rubinstein M., Hackett R., Pitha P., Colmonici. Cloning and expression of a long form of the β subunit of the interferon αβ receptor that is required for signaling. J. Biol. Chem. 270:1995;21606-21611.
18. Engh R. A., Huber R. Accurate bond and angle parameters for X-ray protein structure refinement. Acta Crystallog. sect. A. 47:1991;392-400.
19. Godkin J. D., Bazer F. W., Moffatt J., Sessions F., Roberts R. M. Purification and properties of a major, low molecular weight protein released by the trophoblast of sheep blastocysts at Day 13-21. J. Reprod. Fert. 65:1982;141-150.
20. Imakawa K., Anthony R. V., Kazemin M., Marotti K. R., Polites H. G., Roberts R. M. Interferon-like sequence of ovine trophoblast protein secreted by embryonic trophectoderm. Nature. 330:1987;377-379.
21. Jarpe M. A., Johnson H. M., Bazer F. W., Ott T. L., Curto E. V., Krishna N. R., Pontzer C. H. Predicted structural motif of IFNτ Protein Eng. 7:1994;863-867.
22. Jiang J.-S., Brunger A. T. Protein hydration observed by X-ray diffraction. Solvation properties of penicillopepsin and neuraminidase crystal structures. J. Mol. Biol. 243:1994;100-115.
23. Jones A. T., Kjeldgaard M. O-The Manual, Version 5.9. 1993.
24. Kabsch W. A solution of the best rotation to relate two sets of vectors. Acta Crystallog. sect. A. 32:1976;922-923.
25. Karpusas M., Nolte M., Benton C. B., Meier W., Lipscomb W. N., Goelz S. The crystal structure of human interferon β at 2.2-Å resolution. Proc. Natl Acad. Sci. USA. 94:1997;11813-11818.
26. Laskowski R. J., Macarthur M. W., Moss D. S., Thronton J. M. Procheck: a program to check sterochemical quality of protein structures. J. Appl. Crystallog. 26:1993;283-290.
27. Li J., Roberts R. M. Structure-function relationships in the interferon-τ (IFN-τ). J. Biol. Chem. 269:1994a;13544-13550.
28. Li J., Roberts R. M. Interferon-τ and interferon-α interact with the same receptors in bovine endometroium. J. Biol. Chem. 269:1994b;24826-24833.
29. Matthews B. W. Solvent content of protein crystals. J. Mol. Biol. 33:1968;491-497.
30. Mitsui Y., Senda T., Shimazu T., Matsuda S., Utsumi J. Structural, functional and evolutionary implications of the three-dimensional crystal structure of murine interferon-β Pharmacol. Ther. 58:1993;93-132.
31. Nagabhushan T. L., Giaquinto A. Lubiniecki A. S., Vargo S. A. Biopharmaceutical Production. 1995;221-234 John Wiley & Sons, New York.
32. Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallog. sect. A. 50:1994;157-163.
33. Ott T. L., Van Heeke G., Johnson H. M., Bazer F. W. Cloning and expression in Saccharomyces cerevisiae of a synthetic gene for the type-I trophoblast interferon ovine trophoblast protein-1: purification and antiviral activity. J. Interferon Res. 11:1991;357-364.
34. Otwinowski Z. Maximum likehood refinement of heavy-atom parameters. Wolf W., Evan P. R., Leslie A. G. W. Isomorphous Replacement and Anomalous Scatterings: Proceedings of the CCP4 Study Weekend. 1991;23-38.
35. Otwinowski Z. Oscillation data reduction program. Sawyer L., Isaacs N., Bailey S. Data Collection and Processing: Proceedings of the CCP4 Study Weekend. 1993.
36. Pannu N. S., Read R. J. Improved structure refinement through maximum likelihood. Acta Crystallog. sect. A. 52:1996;659-668.
37. Pellegrini S., Dusanter-Fourt I. The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs). Eur. J. Biochem. 248:1997;615-633.
38. Pestka S. The human interferon-α species and hybrid proteins. Semin. Oncol. 24:1997;4-17.
39. Petricoin E. F., Ito S., Williams B. L., Audet S., Stancato L. F., Gamero A., Clouse K., Grimley P., Weiss A., Beeler J., Finbloom D. S., Shores E. W., Abraham R., Larner A. C. Antiproliferative action of interferon-a requires component of T-cell-receptor signalling. Nature. 390:1997;629-632.
40. Pontzer C. H., Torres B. A., Vallet J. L., Bazer F. W., Johnson H. M. Antiviral activity of the pregnancy recognition hormone ovine trophoblast protein-1. Biochem. Biophys. Res. Commun. 152:1988;801-807.
41. Pontzer C. H., Ott T. L., Bazer F. W., Johnson H. M. Localization of an antiviral site on the pregnancy recognition hormone, oving trophoblast protein 1. Proc. Natl Acad. Sci. USA. 87:1990;5945-5949.
42. Pontzer C. H., Bazer F. W., Johnson H. M. Antiproliferative activity of a pregnancy recognition hormone, ovine trophoblast protein-1. Cancer Res. 51:1991;5304-5307.
43. Pontzer C. H., Ott T. L., Bazer F. W., Johnson H. M. Structure/function studies with interferon tau: evidence for multiple active sites. J. Interferon Res. 14:1994;133-141.
44. Presnell S. R., Cohen F. R. Topological distribution of four-alpha-helix bundles. Proc. Natl Acad. Sci. USA. 86:1989;6592-6596.
45. 2brevealed by X-ray crystallography. Structure. 4:1996;1453-1463.
46. Read R. J. Improved fourier coefficients for maps using phases from partial structures with errors. Acta Crystallog. sect. A. 42:1986;140-149.
47. Rehberg E., Kelder B., Hoal E. G., Pestka S. Specific molecular activities of recombinant and hybrid leukocyte interferons. J. Biol. Chem. 257:1982;11497-11502.
48. Rice L. M., Brunger A. T. Torsion angle dynamics: reduced variable conformational sampling enhances crystallographic structure refinement. Proteins: Struct. Funct. Genet. 19:1994;277-290.
49. Roberts R. M. A role for interferons in early pregnancy. BioEssays. 13:1991;121-126.
50. Roberts R. M., Cross J. C., Leaman D. W. Unique features of the trophoblast interferons. Pharmacol. Ther. 51:1991;329-345.
51. Roberts R. M., Cross J. C., Leaman D. W. Interferons as hormones of pregnancy. Endocrine Rev. 13:1992;432-452.
52. Sack J. S. CHAIN: a crystallographic modeling package. J. Mol. Graph. 6:1988;224-225.
53. Senda T., Saitoh S.-I., Mitsui Y. Refined crystal structure of recombinant murine interferon-β at 2.15 Å resolution. J. Mol. Biol. 253:1995a;187-207.
54. Senda T., Saitoh S.-I., Mitsui Y., Li J., Roberts R. M. A three-dimensional model of interferon-τ J. Interferon Res. 15:1995b;1053-1106.
55. Seto M. H., Harkins R. N., Adler M., Whitlow M., Church W. B., Croze E. Homology model of human interferon-α8 and its receptor complex. Protein Sci. 4:1995;655-670.
56. Sprang S., Bazan J. F. Cytokines structural taxonomy and mechanisms of receptor engagement. Curr. Opin. Struct. Biol. 3:1993;815-827.
57. Strander H. A. Clinical effects of interferon therapy with special emphasis on antitumor efficacy. Acta Oncol. 28:1989;355-362.
58. Subramaniam P. S., Khan S. A., Pontzer C. H., Johnson H. M. Differential recognition of the type I interferon receptor by interferons τ and α is responsible for their disparate cytotoxicities. Proc. Natl Acad. Sci. USA. 92:1995;12270-12274.
59. Uzé G., Luttalla G., Gresser I. Genetic transfer of a functional human interferon α receptor into mouse cells: cloning and expression of its cDNA. Cell. 60:1990;225-234.
60. Uzé G., Di Marco S., Mouchel-Vielh E., Monneron D., Bandu M.-T., Horisberger M. A., Dorques A., Lutfalla G., Mogenson K. E. Domains of interaction between alpha interferon and its receptor components. J. Mol. Biol. 243:1994;245-257.
61. Walter M. R., Nagabhushan T. L. Crystal structure of interleukin 10 reveals an interferon γ-like fold. Biochemistry. 34:1995;12118-12125.
62. Walter M. R., Windsor W. T., Nagabhushan T. L., Lundell D. J., Lunn C. A., Zauodny P. J., Narula S. K. Crystal structure of a complex between interferon-γ and its soluble high-affinity receptor. Nature. 376:1995;230-235.
63. 2biologically active on mouse cells. EMBO J. 6:1987;591-598.
64. Wisconsin Package Version 9.0, Genetics Computer Group (GCG), Madison, Wisc.